Freedom Biosciences
Developer of a biotechnology platform designed for next-generation psychedelic therapeutics. The company offers ketamine-based therapies and combinations of neuropsychiatric drugs to create neuropsych...
Valuation
$60.8M
Market implied
Share Price
N/A
Total Raised
$27.8M
Last Round
Unknown
Latest Funding Round
Unknown
Investors
+21 other investors